By Ateev Bhandari Feb 19 (Reuters) - Wall Street broker Clear Street on Thursday pulled its U.S. listing plan a week after ...

2025 was a slow year for initial public offerings (IPOs), with just 61 companies going public in the U.S. But in 2026, ...

SpaceX is going public soon, but experts warn against common pitfalls for investors hoping to make a quick profit. Learn what ...

One small issuer and four blank check companies went public this past week as the IPO market continued to weather the recent volatility. Read more here.

EIR Biopharma is hoping to bring in $17.1 million from an IPO on the New York Stock Exchange that could fund development of its preclinical eye disease drug. | EIR Biopharma is hoping to bring in $17.

SpaceX's planned 2026 IPO could be good news for space stocks -- but it will more likely be bad news.

Passing qualification one no longer guarantees anything beyond continued review. Yet many companies still build IPO plans as if meeting these metrics alone guarantees a listing outcome and sporadic ...

By Praveen Paramasivam Feb 20 (Reuters) - Indian dairy products maker Milky Mist will push ahead with its planned initial ...

TY AM Group seeks an $18.75 million U.S. IPO despite sharply slowing revenue growth and extreme customer concentration. Click ...

By Rashika Singh Feb 9 (Reuters) - U.S. equity markets are set for a sharp rebound in IPOs in 2026, Goldman Sachs analysts ...

BlockDAG ($BDAG), or Bitcoin Hyper be the strongest upside presales in 2026, or is one simply louder than the rest?

The trio of executives are leaving about five months after the Winklevoss twins took the crypto exchange company public and ...